New Tool: ProSource
Checkout our packaging and processing solutions finder, ProSource.
Start Your Search

Two FDA Vaccine Officials Will Step Down This Fall

Marion Gruber, Ph.D. and Phillip Krause, M.D. were at the center of the COVID-19 vaccine authorization.

According to a recent Boston Globe article, two vaccine officials from the U.S. Food and Drug Administration will leave the agency this fall. The two men are Marion Gruber, Ph.D., Director of FDA Office of Vaccines Research and Review, and Deputy Director Phillip Krause, M.D. Both Gruber and Kraus have been with the FDA for decades, and were key in the agency’s expedited authorization of COVID-19 vaccines amid the pandemic.

Gruber is slated to retire at the end of October, and Krause will depart the following month. The surprise development comes at a crucial time for the FDA’s vaccine review team as it weighs whether to authorize a third Pfizer shot for most Americans, and the user of COVID-19 vaccines in children.

Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Unlock Learning Here
Discover Our Content Hub
Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Take Quiz
Test Your Supply Chain Smarts